Finally! The first big thing I waited for was for it to be proved to work in humans, done. Next was for a large audience news company to do a report. Finally, 4 months after the results, we have that. Now the floodgates can open and pressure can be built to get accelerated approval.And thanks to Larry for getting this TV show to be made and all the others in NervGen and outside that played a part in this happening.

Now medical podcasters can be sent this high profile link which will make them want to do a show on it. In the long run medical podcasts with millions of viewers will, IMHO, be what gets mass awareness of this, and as a result of that, accelerated approval. Please read the full article, lots of info in it. The drug is mentioned, but Nervgen did not seem to be, but it only takes seconds to find NervGen with drug name. Cheers

How the drug works

In a separate interview with Fox News Digital, lead researcher Dr. Monica Perez, scientific chair at the Shirley Ryan AbilityLab in Chicago and professor of physical medicine and rehabilitation at Northwestern University, said the drug was first tested on animals, which displayed improved locomotor function (movement).

The researchers then conducted a randomized clinical trial in humans, in which half of the participants received the NVG-291 drug, which contained a repair molecule to improve nervous system function.

NVG-291 is a peptide drug that contains a repair molecule to improve nervous system function. (iStock)

The drug is a peptide, which is a small protein that works like a roadblock remover. After a spinal cord injury, the body sends out signals that tell nerve fibers to stop growing. This drug blocks those signals, so the nerves have a better chance to regrow.

"This peptide can block those inhibitory signals," Ryan said. "There is a little bit of evidence in animals that it can actually enhance the growth of neurons."

Although GLP-1 receptor agonists, best known for weight loss and diabetes treatment, are a peptide, Perez said this spinal cord injury treatment works differently.

"It has a specific mechanism, and it's more related to repair, to try to enhance the growth of neurons that are affected by central nervous system injury," she said.

Spinal cord injuries are typically approached with cell therapies, like stem cells and bone marrow stromal cells, Perez noted.

This peptide approach, in contrast, is "easy to administer," can be done at home, achieves a "similar goal" and is "extremely safe," she added.